title: Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment.
abstract: Kawasaki disease was initially described by a Japanese paediatrician, Dr Tomisaku Kawasaki, in 1967. He reported an acute mucocutaneous lymph node syndrome affecting the skin, mucosa and lymph nodes. This initial description has since been expanded and is now recognized as Kawasaki disease, an acute systemic selflimiting vasculitis complicated by coronary arterial aneurysms, and even myocardial infarction in some patients (Shulman et al, 1995; Kato et al, 1996; Brogan et al, 2002).
authors.affiliation: Paediatric ST5, London Deanery, Royal London Hospital, Barts and the London NHS Trust, London E1 1BB. beverleyalmeida@doctors.org.uk
authors.forename: Beverley
authors.initials: B
authors.lastname: Almeida
authors.forename: Pauline
authors.initials: P
authors.lastname: Gleeson
authors.forename: Kavita
authors.initials: K
authors.lastname: Chawla
authors.forename: Paul
authors.initials: P
authors.lastname: Brogan
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000628:therapy; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007136:Immunoglobulins; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007136:Immunoglobulins; D001241:Aspirin